Effect of shRNA targeting mouse CD99L2 gene in a murine B cell lymphoma in vitro and in vivo

Oncology Reports

Volumn 29, Issue 4, 2013, Pages 1405-1414

  Liu, Fang ^a,b   Zhang, Gong ^a   Liu, Fanrong ^a   Zhou, Xinhua ^a,b   Chen, Xiaoyan ^b   Han, Xiqun ^a   Wu, Ziqing ^a   Zhao, Tong ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b FOSHAN UNIVERSITY   (China)

Author keywords

A20 cell line; Hodgkin and Reed Sternberg cell; Lymphoma; Mouse CD99 antigen like 2 gene; Nuclear factor B

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTIBODY; CD15 ANTIGEN; CD30 ANTIGEN; CD40 ANTIGEN; CXCL16 CHEMOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 3; LENTIVIRUS VECTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; SHORT HAIRPIN RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; BAGG ALBINO MOUSE; CARCINOGENESIS; CD99L2 GENE; CELL CLONE; CELL CYCLE G2 PHASE; CELL LINE; CELL PROLIFERATION; CELL STRAIN A20; CELL STRUCTURE; DOWN REGULATION; EXPRESSION VECTOR; FEMALE; FLOW CYTOMETRY; GENE; GENE CASSETTE; GENE CONSTRUCT; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOMA CELL; MALE; MICROSCOPY; MOUSE; NONHUMAN; NUDE MOUSE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; TUMOR GROWTH; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD; CELL LINE, TUMOR; CHEMOKINE CCL3; HUMANS; INTERLEUKIN-3; LYMPHOMA, B-CELL; MICE; MICE, INBRED BALB C; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84874706271     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2244     Document Type: Article

References (40)

1. Harley CB, Futcher AB and Greider CW: Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460, 1990.
2. Hahn WC and Meyerson M: Telomerase activation, cellular immortalization and cancer. Ann Med 33: 123-129, 2001.
3. Wright WE and Shay JW: Cellular senescence as a tumor-protection mechanism: the essential role of counting. Curr Opin Genet Dev 11: 98-103, 2001.
4. Kim NW, Piatyszek MA, Prowse KR, et al: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
5. Schaetzlein S, Lucas-Hahn A, Lemme E, et al: Telomere length is reset during early mammalian embryogenesis. Proc Nat Acad Sci USA 101: 8034-8038, 2004.
6. Dahse R, Fiedler W and Ernst G: Telomeres and telomerase: biological and clinical importance. Clin Chem 43: 708-714, 1997.
7. Allsopp RC, Cheshier S and Weissman IL: Telomere shortening accompanies increased cell cycle activity during serial transplan¬tation of hematopoietic stem cells. J Exp Med 193: 917-924, 2001.
8. Son NH, Murray S, Yanovski J, et al: Lineage-specific telomere shortening and unaltered capacity for telomerase expression in human T and B lymphocytes with age. J Immunol 165: 1191 1196, 2000.
9. Masutomi K, Yu EY, Khurts S, et al: Telomerase maintains telomere structure in normal human cells. Cell 114: 241-253, 2003.
10. Hayflick L and Moorhead PS: The serial cultivation of human diploid cell strains. Exp Cell Res 25: 585-621, 1961.
11. Hahn WC and Weinberg RA: Rules for making human tumor cells. N Engl J Med 347: 1593-1603, 2002.
12. Opitz OG, Suliman Y, Hahn WC, et al: Cyclin D1 overexpression and p53 inactivation immortalize primary oral keratinocytes by a telomerase-independent mechanism. J Clin Invest 108: 725-732, 2001.
13. Goessel G, Quante M, Hahn WC, et al: Creating oral squamous cancer cells: a cellular model of oral-esophageal carcinogenesis. Proc Natl Acad Sci USA 102: 15599-15604, 2005.
14. Heeg S, Hirt N, Queisser A, et al: EGFR overexpression induces activation of telomerase via PI3K/AKT-mediated phosphoryla¬tion and transcriptional regulation through Hif1-alpha in a cellular model of oral-esophageal carcinogenesis. Cancer Sci 102: 351-360, 2011.
15. Lansdorp PM, Verwoerd NP, van de Rijke, et al: Heterogeneity in telomere length of human chromosomes. Hum Mol Genet 5: 685-691, 1996.
16. Li S, Rosenberg JE, Donjacour, AA, et al: Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA. Cancer Res 64: 4833-4840, 2004.
17. Pickett HA, Cesare AJ, Johnston RL, et al: Control of telomere length by a trimming mechanism that involves generation of t-circles. EMBO J 28: 799-809, 2009.
18. McEachern MJ and Blackburn EH: Runaway telomere elonga¬tion caused by telomerase RNA gene mutations. Nature 376: 403-409, 1995.
19. Singer MS and Gottschling DE: TLC1: template RNA component of Saccharomyces cerevisiae telomerase. Science 266: 404-409, 1994.
20. Yu GL, Bradley JD, Attardi LD, et al: In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs. Nature 344: 126-132, 1990.
21. Bryan TM, Englezou A, Gupta J, et al: Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14: 4240-4248, 1995.
22. Döbele M, von Werder A, Fulda C, et al: Inhibition of telomerase by mutant template telomerase RNA and anti-telomerase short interfering RNA induces ALT in immortalized human epithelial cells. Z Gastroenterol 44: P281, 2006.
23. Cristofari G and Lingner J: Telomere length homeostasis requires that telomerase levels are limiting. EMBO J 25: 565-574, 2006.
24. Bianchi A and Shore D: How telomerase reaches its end: mechanism of telomerase regulation by the telomeric complex. Mol Cell 31: 153-165, 2008.
25. Smogorzewska A and de Lange T: Regulation of telomerase by telomeric proteins. Annu Rev Biochem 73: 177-208, 2004.
26. Smogorzewska A, van Steensel B, Bianchi A, et al: Control of human telomere length by TRF1 and TRF2. Mol Cell Biol 20: 1659-1668, 2000.
27. Collado M, Blasco MA and Serrano M: Cellular senescence in cancer and aging. Cell 130: 223-233, 2007.
28. Bechter OE, Zou Y, Walker W, et al: Telomeric recombination in mismatch repair deficient human colon cancer cells after telom¬erase inhibition. Cancer Res 64: 3444-3451, 2004.
29. Londono-Vallejo JA, Der-Sarkissian H, Cazes L, et al: Alternative lengthening of telomeres is characterized by high rates of telomeric exchange. Cancer Res 64: 2324-2327, 2004.
30. Broccoli D, Young JW and de Lange T: Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 92: 9082-9086, 1995.
31. Von Werder A: Immortalized human esophageal squamous epithelial cells maintain their telomerases by either telomerase or ALT in a cell cycle-dependent fashion. http://www.biomedsearch.com/sci/immortalized-human-esophageal- squamous-epithelial/ 0040149415.html, 2007.
32. Aldinucci D, Olivo K, Lorenzon D, et al: The role of interleukin-3 in classical Hodgkin's disease. Leuk Lymphoma 46: 303-311, 2005.
33. Niederkorn JY: Emerging concepts in CD8(+) T regulatory cells. Curr Opin Immunol 20: 327-331, 2008.
34. Lee IS, Kim SH, Song HG, et al: The molecular basis for the generation of Hodgkin and Reed-Sternberg cells in Hodgkin's lymphoma. Int J Hematol 77: 330-335, 2003.
35. Hanamoto H, Nakayama T, Miyazato H, et al: Expression of CCL28 by Reed-Sternberg cells defines a major subtype of classical Hodgkin's disease with frequent infiltration of eosino¬phils and/or plasma cells. Am J Pathol 164: 997-1006, 2004.
36. Luft T, Luetjens P, Hochrein H, et al: IFN-alpha enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells. Int Immunol 14: 367-380, 2002.
37. Meijer J, Ogink J, Kreike B, et al: The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation. Cancer Res 68: 4701-4708, 2008.
38. Horie R, Watanabe T, Morishita Y, et al: Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells. Oncogene 21: 2493-2503, 2002.
39. Aldinucci D, Lorenzon D, Cattaruzza L, Pinto A, Gloghini A, Carbone A and Colombatti A: Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: involvement of CCL5/Rantes in tumor cell growth and microen¬vironmental interactions. Int J Cancer 122: 769-776, 2008.
40. Schwarzer R and Jundt F: Notch and NF-?B signaling pathways in the biology of classical Hodgkin lymphoma. Curr Mol Med 11: 236-245, 2011